Effectiveness of monovalent COVID-19 booster/additional vaccine doses in the United States.
Layton JB, Peetluk L, Wong HL, Jiao Y, Djibo DA, Bui C, Lloyd PC, Gruber JF, Miller M, Ogilvie RP, Deng J, Parambi R, Song J, Weatherby LB, Lo AC, Matuska K, Wernecke M, Clarke TC, Cho S, Bell EJ, Seeger JD, Yang GW, Illei D, Forshee RA, Anderson SA, McMahill-Walraven CN, Chillarige Y, Amend KL, Anthony MS, Shoaibi A.
Layton JB, et al. Among authors: weatherby lb.
Vaccine X. 2024 Jan 20;16:100447. doi: 10.1016/j.jvacx.2024.100447. eCollection 2024 Jan.
Vaccine X. 2024.
PMID: 38318230
Free PMC article.